Business Description
Heidelberg Pharma AG
NAICS : 325414
SIC : 2836
ISIN : DE000A11QVV0
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 190.94 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.28 | |||||
Beneish M-Score | -0.33 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.3 | |||||
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | -4.8 | |||||
3-Year Book Growth Rate | 36.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.97 | |||||
9-Day RSI | 51.19 | |||||
14-Day RSI | 48.84 | |||||
6-1 Month Momentum % | 9.82 | |||||
12-1 Month Momentum % | -24.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 2.22 | |||||
Cash Ratio | 1.98 | |||||
Days Inventory | 1625.71 | |||||
Days Sales Outstanding | 24.16 | |||||
Days Payable | 889.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.5 | |||||
Shareholder Yield % | -1.05 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.75 | |||||
Operating Margin % | -295.59 | |||||
Net Margin % | -201.93 | |||||
FCF Margin % | -379.62 | |||||
ROE % | -35.56 | |||||
ROA % | -24.65 | |||||
ROIC % | -92 | |||||
ROC (Joel Greenblatt) % | -454.09 | |||||
ROCE % | -32.96 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 15.44 | |||||
PB Ratio | 3.11 | |||||
Price-to-Tangible-Book | 3.86 | |||||
EV-to-EBIT | -6.08 | |||||
EV-to-Forward-EBIT | -4.37 | |||||
EV-to-EBITDA | -6.39 | |||||
EV-to-Forward-EBITDA | -4.52 | |||||
EV-to-Revenue | 11.91 | |||||
EV-to-Forward-Revenue | 12.66 | |||||
EV-to-FCF | -3.14 | |||||
Price-to-Median-PS-Value | 1.03 | |||||
Price-to-Net-Current-Asset-Value | 4.43 | |||||
Price-to-Net-Cash | 8.6 | |||||
Earnings Yield (Greenblatt) % | -16.45 | |||||
FCF Yield % | -24.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Heidelberg Pharma AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 9.051 | ||
EPS (TTM) (€) | -0.4 | ||
Beta | 1.1 | ||
Volatility % | 45.88 | ||
14-Day RSI | 48.84 | ||
14-Day ATR (€) | 0.051863 | ||
20-Day SMA (€) | 3.006 | ||
12-1 Month Momentum % | -24.12 | ||
52-Week Range (€) | 2.63 - 4.07 | ||
Shares Outstanding (Mil) | 46.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Heidelberg Pharma AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Heidelberg Pharma AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Heidelberg Pharma AG Frequently Asked Questions
What is Heidelberg Pharma AG(XTER:HPHA)'s stock price today?
When is next earnings date of Heidelberg Pharma AG(XTER:HPHA)?
Does Heidelberg Pharma AG(XTER:HPHA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |